For the Inventor, By the Inventor

Enter inventor name

Olney, MD, United States of America

Elise C Kohn

This inventor holds 15 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, The United States of America as Represented by the Secretary of, The United States of America. Active years: 1992-2004.

USPTO Granted Patents = 15

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 7

Forward Citations = 179(Granted Patents)

Company Filing History:

11 out of 1,217

The United States of America as Represented by the Department of Health

The United States of America as Represented by the Secretary of

The United States of America

4. 1 out of 3,690

The United States of America, as Represented by the Secretary, Department of Health and Human Services

Years Active: 1992-2004

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6790936 - CAI resistance proteins and uses thereof (2004-09-14),

2. 6057346 - Inhibition of retroviral LTR promoters by calcium response modifiers (2000-05-02),

3. 5981712 - DNA encoding CAI resistance proteins and uses thereof (1999-11-09),

4. 5880129 - Methods of inhibiting invasion and metastasis of malignant solid tumors (1999-03-09),

5. 5744492 - Method for inhibiting angiogenesis (1998-04-28),

6. 5705514 - Signal transduction inhibitor compounds (1998-01-06),

7. 5652223 - DNA encoding CAI resistance proteins and uses thereof (1997-07-29),

8. 5602156 - Method for inhibiting metalloproteinase expression (1997-02-11),

9. 5565478 - Combination therapy using signal transduction inhibitors with paclitaxel (1996-10-15),

10. 5498620 - Signal transduction inhibitor 1,2,3-triazolo compounds (1996-03-12),

11. 5496804 - Method for treating taxol side-effects with G-CSF (1996-03-05),

12. 5482954 - Signal transduction inhibitor triazole and diazole compounds (1996-01-09),

13. 5405782 - Detection and quantitation method for therapeutic agents in blood (1995-04-11),

14. 5359078 - Signal transduction inhibitor compounds (1994-10-25),

15. 5132315 - Therapeutic application of an anti-invasive compound (1992-07-21),

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]

Loading…